Serum phospholipase A2 in patients with multiple injuries

Area of Science:

• Biochemistry
• Clinical Medicine
• Trauma Research

Background:

• Phospholipase A2 (PLA2) enzymes play critical roles in cellular signaling and inflammation.
• Understanding PLA2 activity in severe injury is crucial for predicting patient outcomes.
• Multiple forms of PLA2 may exist, with differing physiological and pathological relevance.

Purpose of the Study:

• To investigate the catalytic phospholipase A2 activity (CA-PLA2) and immunoreactive pancreatic PLA2 (IR-PLA2) in patients with multiple injuries.
• To explore the relationship between CA-PLA2 levels, mortality, and pulmonary function.
• To determine if IR-PLA2 contributes to the observed CA-PLA2 levels in trauma patients.

Main Methods:

• Measurement of CA-PLA2 and IR-PLA2 in serum samples from 12 patients with multiple injuries (median Injury Severity Score: 41).
• Correlation analysis between CA-PLA2 levels and clinical outcomes (mortality, pulmonary function).
• Immunoadsorption experiments using antiserum to human pancreatic PLA2 to assess the contribution of IR-PLA2 to CA-PLA2.

Main Results:

• CA-PLA2 was elevated in all patients, with higher levels correlating positively with mortality and impaired pulmonary function.
• IR-PLA2 showed only slight increases in nine patients, often with associated blunt abdominal trauma.
• No correlation was found between IR-PLA2 and CA-PLA2 values; immunoadsorption confirmed IR-PLA2 did not account for elevated CA-PLA2.

Conclusions:

• The findings suggest the presence of at least two immunologically distinct phospholipase A2 enzymes in the sera of severely injured patients.
• Elevated CA-PLA2 is a significant indicator of poor prognosis in multiple injury patients.
• Pancreatic PLA2 (IR-PLA2) does not appear to be the primary driver of increased catalytic PLA2 activity in this trauma cohort.